These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 16534004)

  • 1. Dimethyl lithospermate B, an extract of Danshen, suppresses arrhythmogenesis associated with the Brugada syndrome.
    Fish JM; Welchons DR; Kim YS; Lee SH; Ho WK; Antzelevitch C
    Circulation; 2006 Mar; 113(11):1393-400. PubMed ID: 16534004
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cellular mechanisms underlying the effects of milrinone and cilostazol to suppress arrhythmogenesis associated with Brugada syndrome.
    Szél T; Koncz I; Antzelevitch C
    Heart Rhythm; 2013 Nov; 10(11):1720-7. PubMed ID: 23911896
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cellular basis for the Brugada syndrome and other mechanisms of arrhythmogenesis associated with ST-segment elevation.
    Yan GX; Antzelevitch C
    Circulation; 1999 Oct; 100(15):1660-6. PubMed ID: 10517739
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ionic and cellular mechanisms underlying the development of acquired Brugada syndrome in patients treated with antidepressants.
    Minoura Y; Di Diego JM; Barajas-Martínez H; Zygmunt AC; Hu D; Sicouri S; Antzelevitch C
    J Cardiovasc Electrophysiol; 2012 Apr; 23(4):423-32. PubMed ID: 22034916
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms Underlying Epicardial Radiofrequency Ablation to Suppress Arrhythmogenesis in Experimental Models of Brugada Syndrome.
    Patocskai B; Yoon N; Antzelevitch C
    JACC Clin Electrophysiol; 2017 Apr; 3(4):353-363. PubMed ID: 28948234
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of sodium and calcium channel block in unmasking the Brugada syndrome.
    Fish JM; Antzelevitch C
    Heart Rhythm; 2004 Jul; 1(2):210-7. PubMed ID: 15851155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel Na+ channel agonist, dimethyl lithospermate B, slows Na+ current inactivation and increases action potential duration in isolated rat ventricular myocytes.
    Yoon JY; Ahn SH; Oh H; Kim YS; Ryu SY; Ho WK; Lee SH
    Br J Pharmacol; 2004 Nov; 143(6):765-73. PubMed ID: 15504759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cellular basis for trigger and maintenance of ventricular fibrillation in the Brugada syndrome model: high-resolution optical mapping study.
    Aiba T; Shimizu W; Hidaka I; Uemura K; Noda T; Zheng C; Kamiya A; Inagaki M; Sugimachi M; Sunagawa K
    J Am Coll Cardiol; 2006 May; 47(10):2074-85. PubMed ID: 16697328
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brugada syndrome and ischemia-induced ST-segment elevation. Similarities and differences.
    Di Diego JM; Fish JM; Antzelevitch C
    J Electrocardiol; 2005 Oct; 38(4 Suppl):14-7. PubMed ID: 16226068
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effects of quinidine on pinacidil-induced transmural dispersion of repolarization in canine right ventricular wall].
    Luo J; Yang XC; Wang LF; Zhou P; Li CL; Wang MS; Gao Y; Wang LZ
    Zhonghua Xin Xue Guan Bing Za Zhi; 2005 Apr; 33(4):369-71. PubMed ID: 15932676
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cellular and ionic basis for the sex-related difference in the manifestation of the Brugada syndrome and progressive conduction disease phenotypes.
    Fish JM; Antzelevitch C
    J Electrocardiol; 2003; 36 Suppl():173-9. PubMed ID: 14716629
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genotype-phenotype correlation in tissue models of Brugada syndrome simulating patients with sodium and calcium channelopathies.
    Morita H; Zipes DP; Morita ST; Wu J
    Heart Rhythm; 2010 Jun; 7(6):820-7. PubMed ID: 20206324
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cellular and ionic mechanisms underlying the effects of cilostazol, milrinone, and isoproterenol to suppress arrhythmogenesis in an experimental model of early repolarization syndrome.
    Patocskai B; Barajas-Martinez H; Hu D; Gurabi Z; Koncz I; Antzelevitch C
    Heart Rhythm; 2016 Jun; 13(6):1326-34. PubMed ID: 26820510
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Specific therapy based on the genotype and cellular mechanism in inherited cardiac arrhythmias. Long QT syndrome and Brugada syndrome.
    Shimizu W; Aiba T; Antzelevitch C
    Curr Pharm Des; 2005; 11(12):1561-72. PubMed ID: 15892662
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase 2 reentry as a trigger to initiate ventricular fibrillation during early acute myocardial ischemia.
    Yan GX; Joshi A; Guo D; Hlaing T; Martin J; Xu X; Kowey PR
    Circulation; 2004 Aug; 110(9):1036-41. PubMed ID: 15302777
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amplified transmural dispersion of repolarization as the basis for arrhythmogenesis in a canine ventricular-wedge model of short-QT syndrome.
    Extramiana F; Antzelevitch C
    Circulation; 2004 Dec; 110(24):3661-6. PubMed ID: 15569843
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differences in arrhythmogenicity between the canine right ventricular outflow tract and anteroinferior right ventricle in a model of Brugada syndrome.
    Morita H; Zipes DP; Morita ST; Wu J
    Heart Rhythm; 2007 Jan; 4(1):66-74. PubMed ID: 17198993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Electrophysiological effects of ranolazine, a novel antianginal agent with antiarrhythmic properties.
    Antzelevitch C; Belardinelli L; Zygmunt AC; Burashnikov A; Di Diego JM; Fish JM; Cordeiro JM; Thomas G
    Circulation; 2004 Aug; 110(8):904-10. PubMed ID: 15302796
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cellular mechanism and arrhythmogenic potential of T-wave alternans in the Brugada syndrome.
    Fish JM; Antzelevitch C
    J Cardiovasc Electrophysiol; 2008 Mar; 19(3):301-8. PubMed ID: 18031511
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ionic and cellular basis for the predominance of the Brugada syndrome phenotype in males.
    Di Diego JM; Cordeiro JM; Goodrow RJ; Fish JM; Zygmunt AC; Pérez GJ; Scornik FS; Antzelevitch C
    Circulation; 2002 Oct; 106(15):2004-11. PubMed ID: 12370227
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.